Return to: Diabetes News

Global Diabetic Macular Edema Market 2025 by Product Type, Segmentation



The Comprehensive Industry research study titled, “Diabetic Macular Edema Market by Product, Application, Source Type, and Modality - Global Industry Analysis and Forecast To 2025” published by Crystal Market Research, states that the frozen bakery products Market is projected to be around $4 billion by 2025.

The global Diabetic Macular Edema (DME) market is expected to be around $4 billion by 2025. Some of the key factors driving this market are high prevalence of diabetic retinopathy and diabetic macular edema and increasing prevalence of geriatric population around the world. According to the National Center for biotechnology Information, DME is expected to affect around 592 million people by 2035. With such high incidence of DME, the demand for therapies to treat DME is expected to considerably increase during the forecast period. Older adults are more susceptible to diabetes. With increasing prevalence of older population globally, the risk of DME is also expected to increase during the forecast period.

Get sample copy of this Report: https://www.crystalmarketresearch.com/report-sample/HC0682

Based on the indication type, the global diabetic macular edema market is segmented into diffuse diabetic macular edema and focal diabetic macular edema. Focal macular edema is caused due to leakage from microaneurysms which results in hard exudate rings. It is caused due to foci of vascular abnormalities which are associated with an abnormally high permeability. Diffuse macular edema is caused due to dilated retinal capillaries. It is a result of leakage from arterioles, capillaries and microaneurysms.

Corticosteroid therapy can be used to treat patients suffering from recurrent or advanced DME. Corticosteroids are anti-inflammatory non-specific agents and can be effective when administered intravitreally. Grid laser photocoagulation is a standard therapy used for treatment of DME. The laser is applied in a grid-like pattern in order to clear scars that lead to vision loss and blind spots and to destroy the damaged tissue. Implants filled with drugs are also widely used for treating patients with DME caused due to retinal vein occlusion which is one of the common causes leading to macular edema.
North America held a substantial share of the global DME market in 2016 owing to high prevalence of diabetes, high awareness among people about DME and the available treatment options and better reimbursement policies in the region. The region is expected to maintain its dominance over the market during the forecast period. European DME market is expected to show lucrative growth during the forecast period owing to presence of large patient pool in the region.
The key strategy followed by the players operating in the global DME market is product development. These players develop advanced products and therapies to effectively treat recurring or advanced DME and in turn, occupy a larger share of the market. For instance, in February 2015, Genentech, Inc., a subsidiary of the Roche group obtained FDA approval for their Lucentis (ranibizumab injection) 0.3 mg for treating diabetic retinopathy in patients affected by DME. It is administered as an injection by a physician once a month. Some of the key players operating in this market are, Bayer AG, F. Hoffmann-La Roche Ltd., Alimera Sciences, Inc., Regeneron Pharmaceuticals, Inc., Pfizer Inc.,Allergan plc, Novartis AG and Bausch & Lomb Incorporated (acquired by Valeant Pharmaceuticals International, Inc.).
Make Inquiry about Report: https://www.crystalmarketresearch.com/send-an-enquiry/HC0682
Key Market Players:
Bayer AG
F. Hoffmann-La Roche Ltd.
Alimera Sciences Inc.
Regeneron Pharmaceuticals Inc.
Pfizer Inc.
Allergan plc
Novartis AG and Bausch & Lomb Incorporated (acquired by Valeant Pharmaceuticals International
Inc.).

Diabetic Macular Edema Market Segmentation:
By Indication Type:
Diffuse Diabetic Macular Edema
Focal Diabetic Macular Edema
By Treatment Type:
Corticosteroid Therapy
Grid Laser Photocoagulation
Implants
Anti-vascular Endothelial Growth Factor Therapy
Focal Laser Treatment
By End User:
Ophthalmic Clinics
Hospitals
Ambulatory Surgical Centers
Get Customized Report for your region: https://www.crystalmarketresearch.com/customization/HC0682

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Blog: blog.crystalmarketresearch.com
Website: www.crystalmarketresearch ...

News Release: Global Diabetic Macular Edema Market 2025 by Product Type, Segmentation
Submitted on: November 16, 2017 11:36:33 AM
Submitted by: Siddharth
On behalf of: https://www.crystalmarketresearch.com/report-sample/HC0682
advertisement